LEAP2 Is an Endogenous Antagonist of the Ghrelin Receptor

Autor: Yiyuan Yin, Olivier Dalmas, Hadas Galon-Tilleman, Cristina M. Rondinone, Hui Tian, Maria A. Bednarek, Xuecai Ge, Daniel D. Kaplan, Joshua S. Lichtman, Anish Konkar, Peirong Chen, Hong Yang, Yan Wang, Joseph Grimsby, Lutz Jermutus, Michael Chen
Rok vydání: 2017
Předmět:
Zdroj: Cell metabolism. 27(2)
ISSN: 1932-7420
Popis: Summary Ghrelin, an appetite-stimulatory hormone secreted by the stomach, was discovered as a ligand for the growth hormone secretagogue receptor (GHSR). Through GHSR, ghrelin stimulates growth hormone (GH) secretion, a function that evolved to protect against starvation-induced hypoglycemia. Though the biology mediated by ghrelin has been described in great detail, regulation of ghrelin action is poorly understood. Here, we report the discovery of liver-expressed antimicrobial peptide 2 (LEAP2) as an endogenous antagonist of GHSR. LEAP2 is produced in the liver and small intestine, and its secretion is suppressed by fasting. LEAP2 fully inhibits GHSR activation by ghrelin and blocks the major effects of ghrelin in vivo , including food intake, GH release, and maintenance of viable glucose levels during chronic caloric restriction. In contrast, neutralizing antibodies that block endogenous LEAP2 function enhance ghrelin action in vivo . Our findings reveal a mechanism for fine-tuning ghrelin action in response to changing environmental conditions.
Databáze: OpenAIRE